DNA-protein immunization against the GapB and GapC proteins of a mastitis isolate of Staphylococcus aureus

Veterinary Immunology and Immunopathology

Volumn 113, Issue 1-2, 2006, Pages 125-138

  Kerro Dego, Oudessa ^a   Prysliak, Tracy ^a   Potter, Andrew A ^a   Perez Casal, Jose ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

DNA vaccines; Mastitis; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; CHIMERIC PROTEIN; DNA VACCINE; PLASMID DNA; PROTEIN GAPB; PROTEIN GAPC; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; HUMORAL IMMUNITY; IMMUNIZATION; MASTITIS; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; CATTLE; DNA, BACTERIAL; ESCHERICHIA COLI PROTEINS; FEMALE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MASTITIS, BOVINE; MICE; MICE, INBRED C57BL; PLASMIDS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; TRANSFECTION; VACCINES, DNA;

BACTERIA (MICROORGANISMS); BOS TAURUS; STAPHYLOCOCCUS AUREUS;

EID: 33746323313     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.04.004     Document Type: Article

References (39)

1. Argiro L.L., Kohlstadt S.S., Henri S.S., Dessein H.H., Matabiau V.V., Paris P.P., Bourgois A.A., and Dessein A.J. Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH. Vaccine 18 (2000) 2039-2048
2. Bolton A., Song X.M., Willson P., Fontaine M.C., Potter A.A., and Perez-Casal J. Use of the surface proteins GapC and Mig of Streptococcus dysgalactiae as potential protective antigens against bovine mastitis. Can. J. Microbiol. 50 (2004) 423-432
3. Brouillette E., Lacasse P., Shkreta L., Belanger J., Grondin G., Diarra M.S., Fournier S., and Talbot B.G. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus. Vaccine 20 (2002) 2348-2357
4. Brown W.C., Rice-Ficht A.C., and Estes D.M. Bovine type 1 and type 2 responses. Vet. Immunol. Immunopathol. 63 (1998) 45-55
5. Carter E.W., and Kerr D.E. Optimization of DNA-based vaccination in cows using green fluorescent protein and protein A as a prelude to immunization against staphylococcal mastitis. J. Dairy Sci. 86 (2003) 1177-1186
6. Cox G.J., Zamb T.J., and Babiuk L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67 (1993) 5664-5667
7. DeGraves F.J., and Fetrow J. Economics of mastitis and mastitis control. Vet. Clin. North Am. Food Anim. Pract. 9 (1993) 421-434
8. Estes D.M., Closser N.M., and Allen G.K. IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen. Cell Immunol. 154 (1994) 287-295
9. Fitch F.W., McKisic M.D., Lancki D.W., and Gajewski T.F. Differential regulation of murine T lymphocyte subsets. Ann. Rev. Immunol. 11 (1993) 29-48
10. Fontaine M.C., Perez-Casal J., Song X.M., Shelford J., Willson P.J., and Potter A.A. Immunisation of dairy cattle with recombinant Streptococcus uberis GapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge. Vaccine 20 (2002) 2278-2286
11. Gil-Navarro I., Gil M.L., Casanova M., O'Connor J.E., Martinez J.P., and Gozalbo D. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen. J. Bacteriol. 179 (1997) 4992-4999
12. Goji N., Potter A.A., and Perez-Casal J. Characterization of two proteins of Staphylococcus aureus isolated from clinical mastitis with homology to glyceraldehyde-3-phosphate dehydrogenase. Vet. Microbiol. 99 (2004) 269-279
13. Griebel P.J., Brownlie R., Manuja A., Nichani A., Mookherjee N., Popowych Y., Mutwiri G., Hecker R., and Babiuk L.A. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression. Vet. Immunol. Immunopathol. 108 (2005) 11-16
14. Hoedemaker M., Korff B., Edler B., Emmert M., and Bleckmann E. Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle. J. Vet. Med. B Infect. Dis. Vet. Public Health 48 (2001) 373-383
15. Hwang C.Y., Pak S.I., and Han H.R. Effects of autogenous toxoid-bacterin in lactating cows with Staphylococcus aureus subclinical mastitis. J. Vet. Med. Sci. 62 (2000) 875-880
16. Krieg A.M. Immune effects and mechanisms of action of CpG motifs. Vaccine 19 (2000) 618-622
17. Leitner G., Lubashevsky E., Glickman A., Winkler M., Saran A., and Trainin Z. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. I. Challenge trials. Vet. Immunol. Immunopathol. 93 (2003) 31-38
18. Leitner G., Yadlin N., Lubashevsky E., Ezra E., Glickman A., Chaffer M., Winkler M., Saran A., and Trainin Z. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial. Vet. Immunol. Immunopathol. 93 (2003) 153-158
19. Liang R., van den Hurk J.V., Zheng C., Yu H., Pontarollo R.A., Babiuk L.A., and van Drunen Littel-van den Hurk S. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. Vaccine 23 (2005) 5252-5262
20. Manoj S., Babiuk L.A., and van Drunen Littel-van den Hurk S. Approaches to enhance the efficacy of DNA vaccines. Crit. Rev. Clin. Lab. Sci. 41 (2004) 1-39
21. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17 (1996) 138-146
22. Muller-Schollenberger V., Beyer W., Schinitzler P., Merckerbach A., Roth S.H.K.B., and Lucius R. Immunization with Salmonella typhimurium-delivered glyceraldehyde-3-phosphate dehydrogenase protects mice against challenge infection with Echinococcus multilocularis eggs. Int. J. Parasitol. 31 (2001) 1441-1449
23. Ohwada A., Sekiya M., Hanaki H., Arai K.K., Nagaoka I., Hori S., Tominaga S., Hiramatsu K., and Fukuchi Y. DNA vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 44 (1999) 767-774
24. Perez-Casal J., Prysliak T., Kerro-Dego O., and Potter A.A. Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis. Vet. Immunol. Immunopathol. 109 (2006) 85-97
25. Perez-Casal J., Prysliak T., and Potter A.A. A GapC chimera retains the properties of the Streptococcus uberis wild-type GapC protein. Protein Exp. Purif. 33 (2004) 288-296
26. Pontarollo R.A., Babiuk L.A., Hecker R., and Van Drunen Littel-Van Den Hurk S. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J. Gen. Virol. 83 (2002) 2973-2981
27. Pontarollo R.A., Rankin R., Babiuk L.A., Godson D.L., Griebel P.J., Hecker R., Krieg A.M., and van Drunen Littel-van den Hurk S. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet. Immunol. Immunopathol. 84 (2002) 43-59
28. Rankin R., Pontarollo R., Gomis S., Karvonen B., Willson P., Loehr B.I., Godson D.L., Babiuk L.A., Hecker R., and van Drunen Littel-van den Hurk S. CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 20 (2002) 3014-3022
29. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11 (2001) 333-340
30. Rosinha G.M., Myioshi A., Azevedo V., Splitter G.A., and Oliveira S.C. Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation. J. Med. Microbiol. 51 (2002) 661-671
31. Sears P. Staphylococcal vaccines: what are the new strategies. National Mastitis Council Annual Meeting. Orlando, FL (2002) 73-79
32. Shkreta L., Talbot B.G., Diarra M.S., and Lacasse P. Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine 23 (2004) 114-126
33. Tang D.C., DeVit M., and Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356 (1992) 152-154
34. Tenhagen B.A., Edinger D., Baumgartner B., Kalbe P., Klunder G., and Heuwieser W. Efficacy of a herd-specific vaccine against Staphylococcus aureus to prevent post-partum mastitis in dairy heifers. J. Vet. Med. A Physiol. Pathol. Clin. Med. 48 (2001) 601-607
35. Trigona W.L., Brown W.C., and Estes D.M. Functional implications for signaling via the IL4R/IL13R complex on bovine cells. Vet. Immunol. Immunopathol. 72 (1999) 73-79
36. Uwiera R.R., Rankin R., Adams G.P., Pontarollo R., van Drunen Littel-van den Hurk S., Middleton D.M., Babiuk L.A., and Griebel P.J. Effects of intradermally administered plasmid deoxyribonucleic acid on ovine popliteal lymph node morphology. Anat. Rec. 262 (2001) 186-192
37. van Drunen Littel-van den H., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., McCartney D., Watts T., and Babiuk L.A. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79 Pt 4 (1998) 831-839
38. van Drunen Littel-van den Hurk S., Parker M.D., Massie B., van den Hurk J.V., Harland R., Babiuk L.A., and Zamb T.J. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11 (1993) 25-35
39. van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., van den Hurk J.V., Harland R., Babiuk L.A., and Zamb T.J. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12 (1994) 1295-1302